Report Detail
Global (United States, European Union and China) Influenza A Virus, H3N2 Subtype Infections Drug Market Research Report 2019-2025
- RnM3364032 |
- 13 July, 2020 |
- Global |
- 150 Pages |
- QYResearch |
- Pharma & Healthcare
Influenza A Virus, H3N2 Subtype Infections Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Influenza A Virus, H3N2 Subtype Infections Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Influenza A Virus, H3N2 Subtype Infections Drug market is segmented into
NEO-8877
NP-025
NSC-61610
NVINF-1
Others
Segment by Application, the Influenza A Virus, H3N2 Subtype Infections Drug market is segmented into
Clinic
Hospital
Others
Regional and Country-level Analysis
The Influenza A Virus, H3N2 Subtype Infections Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Influenza A Virus, H3N2 Subtype Infections Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Influenza A Virus, H3N2 Subtype Infections Drug Market Share Analysis
Influenza A Virus, H3N2 Subtype Infections Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Influenza A Virus, H3N2 Subtype Infections Drug business, the date to enter into the Influenza A Virus, H3N2 Subtype Infections Drug market, Influenza A Virus, H3N2 Subtype Infections Drug product introduction, recent developments, etc.
The major vendors covered:
AbbVie Inc
AIMM Therapeutics B.V.
Aphios Corporation
Celltrion, Inc.
FluGen, Inc.
Glide Pharmaceutical Technologies Limited
ILiAD Biotechnologies, LLC
Inovio Pharmaceuticals, Inc.
Johnson & Johnson
Medicago Inc.
MedImmune, LLC
Mucosis B.V.
NanoViricides, Inc.
OPKO Health, Inc.
Sarepta Therapeutics, Inc.
VBI Vaccines Inc.
Visterra, Inc.
Zydus Cadila Healthcare Limited
1 Study Coverage
- 1.1 Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction
- 1.2 Market Segments
- 1.3 Key Influenza A Virus, H3N2 Subtype Infections Drug Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size Growth Rate by Type
- 1.4.2 NEO-8877
- 1.4.3 NP-025
- 1.4.4 NSC-61610
- 1.4.5 NVINF-1
- 1.4.6 Others
- 1.5 Market by Application
- 1.5.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size Growth Rate by Application
- 1.5.2 Clinic
- 1.5.3 Hospital
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size, Estimates and Forecasts
- 2.1.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue 2015-2026
- 2.1.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Sales 2015-2026
- 2.2 Global Influenza A Virus, H3N2 Subtype Infections Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Influenza A Virus, H3N2 Subtype Infections Drug Competitor Landscape by Players
- 3.1 Influenza A Virus, H3N2 Subtype Infections Drug Sales by Manufacturers
- 3.1.1 Influenza A Virus, H3N2 Subtype Infections Drug Sales by Manufacturers (2015-2020)
- 3.1.2 Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Manufacturers (2015-2020)
- 3.2 Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Manufacturers
- 3.2.1 Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Manufacturers (2015-2020)
- 3.2.2 Influenza A Virus, H3N2 Subtype Infections Drug Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Influenza A Virus, H3N2 Subtype Infections Drug Revenue in 2019
- 3.2.5 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Influenza A Virus, H3N2 Subtype Infections Drug Price by Manufacturers
- 3.4 Influenza A Virus, H3N2 Subtype Infections Drug Manufacturing Base Distribution, Product Types
- 3.4.1 Influenza A Virus, H3N2 Subtype Infections Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Influenza A Virus, H3N2 Subtype Infections Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into Influenza A Virus, H3N2 Subtype Infections Drug Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size by Type (2015-2020)
- 4.1.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2015-2020)
- 4.1.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Type (2015-2020)
- 4.1.3 Influenza A Virus, H3N2 Subtype Infections Drug Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Forecast by Type (2021-2026)
- 4.2.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Forecast by Type (2021-2026)
- 4.2.3 Influenza A Virus, H3N2 Subtype Infections Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size by Application (2015-2020)
- 5.1.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2015-2020)
- 5.1.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Application (2015-2020)
- 5.1.3 Influenza A Virus, H3N2 Subtype Infections Drug Price by Application (2015-2020)
- 5.2 Influenza A Virus, H3N2 Subtype Infections Drug Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Forecast by Application (2021-2026)
- 5.2.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Influenza A Virus, H3N2 Subtype Infections Drug Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Influenza A Virus, H3N2 Subtype Infections Drug by Country
- 6.1.1 North America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Country
- 6.1.2 North America Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Influenza A Virus, H3N2 Subtype Infections Drug Market Facts & Figures by Type
- 6.3 North America Influenza A Virus, H3N2 Subtype Infections Drug Market Facts & Figures by Application
7 Europe
- 7.1 Europe Influenza A Virus, H3N2 Subtype Infections Drug by Country
- 7.1.1 Europe Influenza A Virus, H3N2 Subtype Infections Drug Sales by Country
- 7.1.2 Europe Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Influenza A Virus, H3N2 Subtype Infections Drug Market Facts & Figures by Type
- 7.3 Europe Influenza A Virus, H3N2 Subtype Infections Drug Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug by Region
- 8.1.1 Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Sales by Region
- 8.1.2 Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Market Facts & Figures by Type
- 8.3 Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Influenza A Virus, H3N2 Subtype Infections Drug by Country
- 9.1.1 Latin America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Country
- 9.1.2 Latin America Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Influenza A Virus, H3N2 Subtype Infections Drug Market Facts & Figures by Type
- 9.3 Central & South America Influenza A Virus, H3N2 Subtype Infections Drug Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug by Country
- 10.1.1 Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Sales by Country
- 10.1.2 Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Market Facts & Figures by Type
- 10.3 Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Market Facts & Figures by Application
11 Company Profiles
- 11.1 AbbVie Inc
- 11.1.1 AbbVie Inc Corporation Information
- 11.1.2 AbbVie Inc Description and Business Overview
- 11.1.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
- 11.1.5 AbbVie Inc Related Developments
- 11.2 AIMM Therapeutics B.V.
- 11.2.1 AIMM Therapeutics B.V. Corporation Information
- 11.2.2 AIMM Therapeutics B.V. Description and Business Overview
- 11.2.3 AIMM Therapeutics B.V. Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 AIMM Therapeutics B.V. Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
- 11.2.5 AIMM Therapeutics B.V. Related Developments
- 11.3 Aphios Corporation
- 11.3.1 Aphios Corporation Corporation Information
- 11.3.2 Aphios Corporation Description and Business Overview
- 11.3.3 Aphios Corporation Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Aphios Corporation Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
- 11.3.5 Aphios Corporation Related Developments
- 11.4 Celltrion, Inc.
- 11.4.1 Celltrion, Inc. Corporation Information
- 11.4.2 Celltrion, Inc. Description and Business Overview
- 11.4.3 Celltrion, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Celltrion, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
- 11.4.5 Celltrion, Inc. Related Developments
- 11.5 FluGen, Inc.
- 11.5.1 FluGen, Inc. Corporation Information
- 11.5.2 FluGen, Inc. Description and Business Overview
- 11.5.3 FluGen, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 FluGen, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
- 11.5.5 FluGen, Inc. Related Developments
- 11.6 Glide Pharmaceutical Technologies Limited
- 11.6.1 Glide Pharmaceutical Technologies Limited Corporation Information
- 11.6.2 Glide Pharmaceutical Technologies Limited Description and Business Overview
- 11.6.3 Glide Pharmaceutical Technologies Limited Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Glide Pharmaceutical Technologies Limited Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
- 11.6.5 Glide Pharmaceutical Technologies Limited Related Developments
- 11.7 ILiAD Biotechnologies, LLC
- 11.7.1 ILiAD Biotechnologies, LLC Corporation Information
- 11.7.2 ILiAD Biotechnologies, LLC Description and Business Overview
- 11.7.3 ILiAD Biotechnologies, LLC Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 ILiAD Biotechnologies, LLC Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
- 11.7.5 ILiAD Biotechnologies, LLC Related Developments
- 11.8 Inovio Pharmaceuticals, Inc.
- 11.8.1 Inovio Pharmaceuticals, Inc. Corporation Information
- 11.8.2 Inovio Pharmaceuticals, Inc. Description and Business Overview
- 11.8.3 Inovio Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Inovio Pharmaceuticals, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
- 11.8.5 Inovio Pharmaceuticals, Inc. Related Developments
- 11.9 Johnson & Johnson
- 11.9.1 Johnson & Johnson Corporation Information
- 11.9.2 Johnson & Johnson Description and Business Overview
- 11.9.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Johnson & Johnson Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
- 11.9.5 Johnson & Johnson Related Developments
- 11.10 Medicago Inc.
- 11.10.1 Medicago Inc. Corporation Information
- 11.10.2 Medicago Inc. Description and Business Overview
- 11.10.3 Medicago Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Medicago Inc. Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
- 11.10.5 Medicago Inc. Related Developments
- 11.1 AbbVie Inc
- 11.1.1 AbbVie Inc Corporation Information
- 11.1.2 AbbVie Inc Description and Business Overview
- 11.1.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
- 11.1.5 AbbVie Inc Related Developments
- 11.12 Mucosis B.V.
- 11.12.1 Mucosis B.V. Corporation Information
- 11.12.2 Mucosis B.V. Description and Business Overview
- 11.12.3 Mucosis B.V. Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Mucosis B.V. Products Offered
- 11.12.5 Mucosis B.V. Related Developments
- 11.13 NanoViricides, Inc.
- 11.13.1 NanoViricides, Inc. Corporation Information
- 11.13.2 NanoViricides, Inc. Description and Business Overview
- 11.13.3 NanoViricides, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 NanoViricides, Inc. Products Offered
- 11.13.5 NanoViricides, Inc. Related Developments
- 11.14 OPKO Health, Inc.
- 11.14.1 OPKO Health, Inc. Corporation Information
- 11.14.2 OPKO Health, Inc. Description and Business Overview
- 11.14.3 OPKO Health, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 OPKO Health, Inc. Products Offered
- 11.14.5 OPKO Health, Inc. Related Developments
- 11.15 Sarepta Therapeutics, Inc.
- 11.15.1 Sarepta Therapeutics, Inc. Corporation Information
- 11.15.2 Sarepta Therapeutics, Inc. Description and Business Overview
- 11.15.3 Sarepta Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Sarepta Therapeutics, Inc. Products Offered
- 11.15.5 Sarepta Therapeutics, Inc. Related Developments
- 11.16 VBI Vaccines Inc.
- 11.16.1 VBI Vaccines Inc. Corporation Information
- 11.16.2 VBI Vaccines Inc. Description and Business Overview
- 11.16.3 VBI Vaccines Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 VBI Vaccines Inc. Products Offered
- 11.16.5 VBI Vaccines Inc. Related Developments
- 11.17 Visterra, Inc.
- 11.17.1 Visterra, Inc. Corporation Information
- 11.17.2 Visterra, Inc. Description and Business Overview
- 11.17.3 Visterra, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.17.4 Visterra, Inc. Products Offered
- 11.17.5 Visterra, Inc. Related Developments
- 11.18 Zydus Cadila Healthcare Limited
- 11.18.1 Zydus Cadila Healthcare Limited Corporation Information
- 11.18.2 Zydus Cadila Healthcare Limited Description and Business Overview
- 11.18.3 Zydus Cadila Healthcare Limited Sales, Revenue and Gross Margin (2015-2020)
- 11.18.4 Zydus Cadila Healthcare Limited Products Offered
- 11.18.5 Zydus Cadila Healthcare Limited Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Influenza A Virus, H3N2 Subtype Infections Drug Market Estimates and Projections by Region
- 12.1.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Forecast by Regions 2021-2026
- 12.1.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Forecast by Regions 2021-2026
- 12.2 North America Influenza A Virus, H3N2 Subtype Infections Drug Market Size Forecast (2021-2026)
- 12.2.1 North America: Influenza A Virus, H3N2 Subtype Infections Drug Sales Forecast (2021-2026)
- 12.2.2 North America: Influenza A Virus, H3N2 Subtype Infections Drug Revenue Forecast (2021-2026)
- 12.2.3 North America: Influenza A Virus, H3N2 Subtype Infections Drug Market Size Forecast by Country (2021-2026)
- 12.3 Europe Influenza A Virus, H3N2 Subtype Infections Drug Market Size Forecast (2021-2026)
- 12.3.1 Europe: Influenza A Virus, H3N2 Subtype Infections Drug Sales Forecast (2021-2026)
- 12.3.2 Europe: Influenza A Virus, H3N2 Subtype Infections Drug Revenue Forecast (2021-2026)
- 12.3.3 Europe: Influenza A Virus, H3N2 Subtype Infections Drug Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Influenza A Virus, H3N2 Subtype Infections Drug Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Influenza A Virus, H3N2 Subtype Infections Drug Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Influenza A Virus, H3N2 Subtype Infections Drug Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Influenza A Virus, H3N2 Subtype Infections Drug Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Influenza A Virus, H3N2 Subtype Infections Drug Sales Forecast (2021-2026)
- 12.5.2 Latin America: Influenza A Virus, H3N2 Subtype Infections Drug Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Influenza A Virus, H3N2 Subtype Infections Drug Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Influenza A Virus, H3N2 Subtype Infections Drug Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Influenza A Virus, H3N2 Subtype Infections Drug Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Influenza A Virus, H3N2 Subtype Infections Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Influenza A Virus, H3N2 Subtype Infections Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Influenza A Virus, H3N2 Subtype Infections Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Influenza A Virus, H3N2 Subtype Infections Drug. Industry analysis & Market Report on Influenza A Virus, H3N2 Subtype Infections Drug is a syndicated market report, published as Global (United States, European Union and China) Influenza A Virus, H3N2 Subtype Infections Drug Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Influenza A Virus, H3N2 Subtype Infections Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
